One promising strategy to inhibit angiogenesis in neuroblastoma is to target the signaling pathway of HGF (also known as scatter factor, SF) along with its receptor HGFR (also known as c-Met) that plays important roles in mitogenic, motogenic, and morphogenic regulation of angiogenesis, tumor growth, and metastasis. The gene discussed is KITLG; the disease is neuroblastoma.